Hst Global, Inc. (HSTC) — SEC Filings
Hst Global, Inc. (HSTC) — 9 SEC filings. Latest: 10-K (Nov 3, 2025). Includes 4 8-K, 3 10-Q, 2 10-K.
View Hst Global, Inc. on SEC EDGAR
Overview
Hst Global, Inc. (HSTC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Nov 3, 2025: HST Global, Inc. reported a significant financial turnaround for the fiscal year ended December 31, 2024. The company achieved revenues of $15.2 million, a substantial increase from the previous year, driven by strong performance in its pharmaceutical preparations segment. Net income reached $2.8 mi
Sentiment Summary
Across 9 filings, the sentiment breakdown is: 1 bullish, 8 neutral. The dominant filing sentiment for Hst Global, Inc. is neutral.
Filing Type Overview
Hst Global, Inc. (HSTC) has filed 2 10-K, 4 8-K, 3 10-Q with the SEC between Apr 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (9)
| Date | Form | Description | Risk |
|---|---|---|---|
| Nov 3, 2025 | 10-K | HST Global Swings to Profit on Strong Pharma Sales | medium |
| Mar 20, 2025 | 8-K | HST Global, Inc. Files 8-K for Acquisition and Equity Sales | medium |
| Nov 22, 2024 | 10-Q | HST Global, Inc. Files Q3 2024 10-Q | low |
| Nov 12, 2024 | 8-K | HST Global, Inc. Files 8-K for Acquisition and Equity Sales | medium |
| Sep 26, 2024 | 8-K | HST Global, Inc. Files 8-K: Material Agreement & Equity Sales | medium |
| Aug 26, 2024 | 10-Q | HST Global, Inc. Files 10-Q for Q2 2024 | low |
| Jun 5, 2024 | 10-Q | HST Global, Inc. Files Q1 2024 10-Q | low |
| May 3, 2024 | 8-K | HST Global Reports Material Agreements & Control Changes | medium |
| Apr 5, 2024 | 10-K | HST Global, Inc. Files Annual Report on Form 10-K for Fiscal Year Ended December 31, 2023 | medium |
Risk Profile
Risk Assessment: Of HSTC's 9 recent filings, 0 were flagged as high-risk, 6 as medium-risk, and 3 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $15.2M |
| Net Income | $2.8M |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | N/A |
| Operating Margin | N/A |
| Total Assets | N/A |
| Total Debt | N/A |
Industry Context
HST Global operates within the pharmaceutical preparations industry, a sector characterized by high R&D investment, stringent regulatory oversight, and intense competition. Key trends include the ongoing demand for innovative treatments, the increasing importance of biologics, and the growing influence of emerging markets.
Top Tags
equity-sale (4) · financials (4) · 10-Q (3) · pharmaceuticals (3) · acquisition (2) · filing (2) · material-agreement (2) · Pharmaceuticals (1) · Earnings (1) · Turnaround (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $15.2M | Significant increase from previous year, driving profitability. |
| Net Income | $2.8M | Dramatic turnaround from a net loss in 2023. |
| Cash from Divestitures | $3.5M | Generated from strategic sale of non-core assets. |
| G&A Expense Reduction | 15% | Contributed to improved operational efficiency. |
| R&D Allocation | $4.1M | Planned investment for new drug development in 2025. |
| SEC File Number | 000-15303 | Identifies the company's filing history with the SEC. |
| IRS Employer Identification No. | 73-1215433 | Company's tax identification number. |
| Film Number | 241325857 | Internal SEC processing number for the filing. |
| Reporting Period | 2024 Q2 | Indicates the second quarter of 2024 as the period covered by the report. |
| Fiscal Year End | 1231 | Specifies December 31st as the company's fiscal year end. |
| Commission File Number | 000-15303 | SEC file number for HST Global, Inc. |
| SIC Code | 2834 | Standard Industrial Classification for Pharmaceutical Preparations. |
| Date of Name Change | 2004-10-19 | Date when the company changed its name from NT HOLDING CORP. |
Frequently Asked Questions
What are the latest SEC filings for Hst Global, Inc. (HSTC)?
Hst Global, Inc. has 9 recent SEC filings from Apr 2024 to Nov 2025, including 4 8-K, 3 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of HSTC filings?
Across 9 filings, the sentiment breakdown is: 1 bullish, 8 neutral. The dominant sentiment is neutral.
Where can I find Hst Global, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Hst Global, Inc. (HSTC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Hst Global, Inc.?
Key financial highlights from Hst Global, Inc.'s most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for HSTC?
The investment thesis for HSTC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Hst Global, Inc.?
Executive information for Hst Global, Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Hst Global, Inc. stock?
Of HSTC's 9 assessed filings, 0 were flagged high-risk, 6 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Hst Global, Inc.?
Forward guidance and predictions for Hst Global, Inc. are extracted from SEC filings as they are enriched.